Oral & Topical Anaesthetics Market
Oral & Topical Anaesthetics Market Study by Non-Aqueous and Aqueous through Gels, Ointments, Solutions, and Adhesive Patch Administration From 2024 to 2034
Analysis of Oral & Topical Anaesthetics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Oral & Topical Anaesthetics Market Outlook (2024 to 2034)
The global oral & topical anaesthetics market is evaluated to reach a valuation of US$ 791.9 million in 2024 and further expand at a CAGR of 8% to end up at US$ 1.71 billion by 2034.
Dental anaesthesia is the term used to describe the use of anaesthetics in dentistry. General anaesthesia, sedation, and local anaesthetics are all included in this. The most common local anaesthetic in dentistry is lidocaine. Lidocaine has a half-life of one and a half to two hours in the body.
During dental operations, lidocaine is most commonly used to numb the area surrounding a tooth. For example, compared to a simple filling, more lidocaine is required for root canal treatment. Dental operations are now simpler and more pleasant thanks to developments in sedation and anaesthesia.
By injecting an anaesthetic solution close to the nerves that supply feeling to the region of the oral cavity undergoing treatment, local anaesthesia is accomplished. In dentistry, using an anaesthetic to remove teeth is a standard procedure.
The most crucial competency for dentists is the ability to provide local anaesthetic for tooth extractions safely and efficiently. The most frequent cause of patient concern is probably the local anaesthetic injection.
For dentists, the inability to provide appropriate pain management with little discomfort remains a top worry. Understanding the anaesthetic drugs, the neuroanatomy involved, and the best methods and tools available are all necessary for providing effective local anaesthesia.
The dentist has several alternatives for efficiently controlling the discomfort involved in dental treatments thanks to agents and anaesthetic delivery devices. In the upcoming years, it is anticipated that the development of better, more advanced tools and methods for attaining deep anaesthesia will accelerate industry advancement.
An FDA phase 3 trial is testing a nasal spray that anesthetizes the maxillary anterior six teeth. The experiment compares the efficacy of the spray to the existing unpleasant anaesthetic injections. A novel dental tool called the Syringe Micro Vibrator (SMV) lessens the discomfort and anxiety that come with intraoral injections.
| Report Attribute | Detail |
|---|---|
| Oral & Topical Anaesthetics Market Size (2024E) | US$ 791.9 Million |
| Forecasted Market Value (2034F) | US$ 1.71 Billion |
| Global Market Growth Rate (2024 to 2034) | 8% CAGR |
| North America Market Value (2024E) | US$ 267.4 Million |
| Japan Market Value (2034F) | US$ 66 Million |
| Dental Clinics Segment Growth Rate (2024 to 2034) | 7.9% CAGR |
| Non-aqueous Segment Value (2034F) | US$ 1.12 Billion |
| Key Companies Profiled | Astra Zeneca; Septodont; Dentsply; Sirona; GlaxoSmithKline PLC; Gilead Sciences Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Baxter International Inc.; Abbott Laboratories; Hospira, Inc.; Hikma Pharmaceuticals PLC; AbbVie Inc.; Fresenius Se & Co. Kgaa |
Anaesthesia is a reversible loss sensation, which is induced by a drug known as anaesthetics. Amongst these drugs, oral & topical anaesthetics are the drugs that reversibly block nerve conduction in and around the target site of administration, mainly in the mouth or oral sites.
Oral & topical anaesthetics penetrate mucosal surfaces of the mouth more easily than through a keratinized surface because of the absence of a stratum corneum (through the openings of the hair follicles and sweat glands.
Oral & topical anaesthetics are widely used in anaesthesia, dentistry, and aesthetic surgery as they cause superficial loss of pain sensation after direct application. Local oral & topical anaesthetics remain major healthcare tools for pain control in anaesthesia, oral, and dentistry.
However, research and development are still undergoing to seek new products in the oral & topical anaesthetics market for managing pain. Most of the oral & topical anaesthetics researches are focused on improvement in the area of anaesthetic agents and routes of administration, such as gels, ointments, solutions, and adhesive patches.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Oral & Topical Anaesthetics Market: Drivers and Restraints
The global oral & topical anaesthetics market is primarily driven by the increase in the incidences of dental-associated problems and diseases. Some other driving factors in the oral & topical anaesthetics market include increased awareness amongst the population about oral care, government healthcare initiatives, and training programs, an increase in dental patients, and oral cosmetic surgeries.
Moreover, an increase in the number of anesthesiologists and dentists globally will also propel the growth of the oral & topical anaesthetics market.
However, stringent regulatory guidelines for drug approval, availability of skilled anesthesiologists and dentists, and side effects of anaesthetic drugs affect the growth of the global oral & topical anaesthetics market. In addition, poor healthcare infrastructure in low economic countries will impede the growth oral & topical anaesthetics market over the forecast period.
Oral & Topical Anaesthetics Market: Overview
Globally, the oral & topical anaesthetics market will witness growth due to several factors, which include the emergence of new drug products in oral tropical care, increase in dental patients, rise and awareness in disposable income in developing nations, demand for oral care, and need for improved and less painful anaesthetic administration.
According to The Lancet Commission on Global Health 2015, around 5 billion people worldwide lack access to surgical and aesthetic care, and most of these are in lower-income countries. Therefore leading drug manufacturers are focused on providing new and innovative generic oral & topical anaesthetics drugs, which will not only improve painless treatment but also incur low medical costs.
Furthermore, the entering of new players into oral & topical anaesthetics is also expected to create a healthy competitive environment in the market during the forecast period.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Oral & Topical Anaesthetics Market: Regional Outlook
Region-wise, the global market is classified into regions namely North America, Latin America, Europe, CIS & Russia, Japan, Asia Pacific Excluding Japan, ASEAN Countries, Middle East, and Africa. North America will lead the market due to high healthcare investments, presence in major pharmaceutical research hubs, and high standard of living. The European market will be noteworthy and will flourish thanks to the increasing number of medical professionals and growing awareness.
The steady increase in the number of dentists and anesthesiologist in Europe specifically in Germany, France, the United Kingdom, and Italy will propel the market growth of Market in the region. Asia Pacific will be the fastest growing market, as it comprises large and small healthcare entities, which provides scope for healthy competition and growth opportunities.
Latin American market is expected to hold the fifth largest market share after Asia Pacific due to the increasing trend towards a competitive environment amongst drug manufacturers and medical awareness among the population.
Japan, being a developed economy will have a major contribution to the market. However, CIS & Russia will have moderate growth in the market due to the average customer base. The Middle East and Africa will hold the lowest share of the market, owing to average medical facilities, poor political environment in Africa, and low funding.
Oral & Topical Anaesthetics Market: Key Players
Some of the key players operating in the global market are
- Astra Zeneca
- Septodont
- Dentsply
- Sirona
- GlaxoSmithKline PLC
- Gilead Sciences Inc.
- Johnson & Johnson
- F. Hoffmann-La Roche Ltd.
- Baxter International Inc.
- Abbott Laboratories
- Hospira, Inc.
- Hikma Pharmaceuticals PLC
- AbbVie Inc.
- Fresenius Se & Co. Kgaa
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of several market factors on market segments and geographies.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The report covers an exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Segmentation of the Oral & Topical Anaesthetics Market Research
-
By Drug Class Type :
- Non-aqueous
- Aqueous
-
By Routes of Administration :
- Gels
- Ointments
- Solutions
- Adhesive Patch
-
By Duration of Action :
- Short
- Medium
- Long
-
By Distribution Channel :
- Hospitals
- Dental Clinics
- Pharmacies and Drug Stores
- e-Commerce
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Drug Class Type
- 6.2. Route Of Administration
- 6.3. Duration Of Action
- 6.4. Distribution Channel
- 7. Global Market Analysis and Forecast, By Drug Class Type
- 7.1. Non-aqueous
- 7.2. Aqueous
- 8. Global Market Analysis and Forecast, By Route Of Administration
- 8.1. Gels
- 8.2. Ointments
- 8.3. Solutions
- 8.4. Adhesive Patch
- 9. Global Market Analysis and Forecast, By Duration Of Action
- 9.1. Short
- 9.2. Medium
- 9.3. Long
- 10. Global Market Analysis and Forecast, By Distribution Channel
- 10.1. Hospitals
- 10.2. Dental Clinics
- 10.3. Pharmacies and Drug Stores
- 10.4. E-commerce
- 11. Global Market Analysis and Forecast, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. Western Europe
- 11.4. Eastern Europe
- 11.5. Asia Pacific
- 11.6. East Asia
- 11.7. MEA
- 12. North America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 14. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 16. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 17. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 18. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 19. Sales Forecast by Drug Class Type, Route Of Administration, Duration Of Action, and Distribution Channel for 30 Countries
- 20. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 21. Company Profile
- 21.1. Astra Zeneca (UK)
- 21.2. Septodont (US)
- 21.3. Dentsply (US)
- 21.4. Sirona (US)
- 21.5. GlaxoSmithKline PLC (US)
- 21.6. Gilead Sciences Inc. (US)
- 21.7. Johnson & Johnson (US)
- 21.8. F. Hoffmann-La Roche Ltd. (Switzerland)
- 21.9. Baxter International Inc. (US)
- 21.10. Abbott Laboratories (US)
- 21.11. Hospira, Inc. (US)
- 21.12. Hikma Pharmaceuticals PLC (UK)
- 21.13. AbbVie Inc. (US)
- 21.14. Fresenius Se & Co. Kgaa (Germany)
- 21.15. Others
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Drug Class Type
Table 3: Global Market US$ Mn Forecast by Route Of Administration
Table 4: Global Market US$ Mn Forecast by Duration Of Action
Table 5: Global Market US$ Mn Forecast by Distribution Channel
Table 6: North America Market US$ Mn Forecast by Country
Table 7: North America Market US$ Mn Forecast by Drug Class Type
Table 8: North America Market US$ Mn Forecast by Route Of Administration
Table 9: North America Market US$ Mn Forecast by Duration Of Action
Table 10: North America Market US$ Mn Forecast by Distribution Channel
Table 11: Latin America Market US$ Mn Forecast by Country
Table 12: Latin America Market US$ Mn Forecast by Drug Class Type
Table 13: Latin America Market US$ Mn Forecast by Route Of Administration
Table 14: Latin America Market US$ Mn Forecast by Duration Of Action
Table 15: Latin America Market US$ Mn Forecast by Distribution Channel
Table 16: Western Europe Market US$ Mn Forecast by Country
Table 17: Western Europe Market US$ Mn Forecast by Drug Class Type
Table 18: Western Europe Market US$ Mn Forecast by Route Of Administration
Table 19: Western Europe Market US$ Mn Forecast by Duration Of Action
Table 20: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 21: Eastern Europe Market US$ Mn Forecast by Country
Table 22: Eastern Europe Market US$ Mn Forecast by Drug Class Type
Table 23: Eastern Europe Market US$ Mn Forecast by Route Of Administration
Table 24: Eastern Europe Market US$ Mn Forecast by Duration Of Action
Table 25: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 26: Asia Pacific Market US$ Mn Forecast by Country
Table 27: Asia Pacific Market US$ Mn Forecast by Drug Class Type
Table 28: Asia Pacific Market US$ Mn Forecast by Route Of Administration
Table 29: Asia Pacific Market US$ Mn Forecast by Duration Of Action
Table 30: Asia Pacific Market US$ Mn Forecast by Distribution Channel
Table 31: East Asia Market US$ Mn Forecast by Country
Table 32: East Asia Market US$ Mn Forecast by Drug Class Type
Table 33: East Asia Market US$ Mn Forecast by Route Of Administration
Table 34: East Asia Market US$ Mn Forecast by Duration Of Action
Table 35: East Asia Market US$ Mn Forecast by Distribution Channel
Table 36: MEA Market US$ Mn Forecast by Country
Table 37: MEA Market US$ Mn Forecast by Drug Class Type
Table 38: MEA Market US$ Mn Forecast by Route Of Administration
Table 39: MEA Market US$ Mn Forecast by Duration Of Action
Table 40: MEA Market US$ Mn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 5: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 9: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 10: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 13: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 14: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 15: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 17: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 18: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 19: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 22: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 23: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 24: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 25: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 26: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 27: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 28: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 29: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 30: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 31: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 32: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 33: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 34: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 35: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 36: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Drug Class Type
Figure 37: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Route Of Administration
Figure 38: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Duration Of Action
Figure 39: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 40: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What will be the demand outlook for the oral & topical anaesthetics market?
The oral & topical anaesthetics market is estimated to garner a market value of US$ 791.9 million in 2024.
Which region will spearhead the growth in the global market?
North America is evaluated to possess a 36.9% market share for the market by 2034.
What is the forecasted growth rate for the global market through 2034?
The global market is analyzed to register a CAGR of 8% in the forecast period 2024 to 2034.
Oral & Topical Anaesthetics Market